<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zurnadzhy L</submitter><funding>Japan Society for the Promotion of Science</funding><pagination>882727</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9159157</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>With time after the Chernobyl accident, the number of papillary thyroid carcinomas (PTCs) driven by the BRAF&lt;sup>V600E&lt;/sup> oncoprotein is growing in patients exposed to radiation at a young age. Clinicopathological associations of BRAF&lt;sup>V600E&lt;/sup> in PTCs from patients with internal radiation history have not been sufficiently studied so far. This work analyzes the structural characteristics, proliferative activity, invasive features, clinical information, and dosimetric data in the BRAF&lt;sup>V600E&lt;/sup>-positive and BRAF&lt;sup>V600E&lt;/sup>-negative PTCs from the Ukrainian patients exposed to Chernobyl radiation and treated over 30 years after the accident. The study included 428 PTCs from patients aged 4-49 years at surgery who lived in the six northern regions of Ukraine most contamina</pubmed_abstract><journal>Frontiers in medicine</journal><pubmed_title>Clinicopathological Implications of the &lt;i>BRAF&lt;/i> &lt;sup>&lt;i>V&lt;/i>600&lt;i>E&lt;/i>&lt;/sup> Mutation in Papillary Thyroid Carcinoma of Ukrainian Patients Exposed to the Chernobyl Radiation in Childhood: A Study for 30 Years After the Accident.</pubmed_title><pmcid>PMC9159157</pmcid><funding_grant_id>19K07471</funding_grant_id><funding_grant_id>19KK02670001</funding_grant_id><funding_grant_id>20KK0217</funding_grant_id><pubmed_authors>Bolgov M</pubmed_authors><pubmed_authors>Masiuk S</pubmed_authors><pubmed_authors>Saenko VA</pubmed_authors><pubmed_authors>Chernyshov S</pubmed_authors><pubmed_authors>Yamashita S</pubmed_authors><pubmed_authors>Zurnadzhy L</pubmed_authors><pubmed_authors>Bogdanova T</pubmed_authors><pubmed_authors>Mitsutake N</pubmed_authors><pubmed_authors>Ito M</pubmed_authors><pubmed_authors>Tronko M</pubmed_authors><pubmed_authors>Rogounovitch TI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinicopathological Implications of the &lt;i>BRAF&lt;/i> &lt;sup>&lt;i>V&lt;/i>600&lt;i>E&lt;/i>&lt;/sup> Mutation in Papillary Thyroid Carcinoma of Ukrainian Patients Exposed to the Chernobyl Radiation in Childhood: A Study for 30 Years After the Accident.</name><description>With time after the Chernobyl accident, the number of papillary thyroid carcinomas (PTCs) driven by the BRAF&lt;sup>V600E&lt;/sup> oncoprotein is growing in patients exposed to radiation at a young age. Clinicopathological associations of BRAF&lt;sup>V600E&lt;/sup> in PTCs from patients with internal radiation history have not been sufficiently studied so far. This work analyzes the structural characteristics, proliferative activity, invasive features, clinical information, and dosimetric data in the BRAF&lt;sup>V600E&lt;/sup>-positive and BRAF&lt;sup>V600E&lt;/sup>-negative PTCs from the Ukrainian patients exposed to Chernobyl radiation and treated over 30 years after the accident. The study included 428 PTCs from patients aged 4-49 years at surgery who lived in the six northern regions of Ukraine most contamina</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T19:12:35.766Z</modification><creation>2024-11-13T12:16:42.67Z</creation></dates><accession>S-EPMC9159157</accession><cross_references><pubmed>35665338</pubmed><doi>10.3389/fmed.2022.882727</doi></cross_references></HashMap>